speb/financial-data huggingface dataset:
Financial ratios for BETR — quarterly report dated 2025-12-31
Total revenue: 66501000
Gross profit: -11405000
Operating income: -41934000
Net income: -39920000
Capital expenditures: 344000
Operating cash flow: -57270000
Depreciation & amortization: 3161000
Net tangible assets: 4203000
Owner earnings: -37103000
Return on net tangible assets (%): -882.774208898406
Buffett classification: The Gruesome
Stock price: 32.58
Shares outstanding: 13086244
Book value: 37183000
P/B ratio: 11.466256878681117
Market cap (USD): 426349829.52
Debt to equity: 16.547696527983216
Current ratio: 1.1652154849407677
Quick ratio: 1.1652154849407677
COGS to revenue (%): 117.1501180433377
SG&A to revenue (%): 30.161952451842826
Free cash flow (dilution-adjusted): -68123000
Buyback yield (%): 0
Retained earnings: -2076238000
Receivables turnover: 0.05491121856483225
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.703179395667863
FCF margin (%): -102.43906106675087
Revenue growth (%): 21.32562212654163
Rule of 40 score: -81.11343894020924
Financial ratios for BETR — annual report dated 2025-12-31
Total revenue: 206895000
Gross profit: -24674000
Operating income: -149475000
Net income: -165872000
Capital expenditures: 1193000
Operating cash flow: -166575000
Depreciation & amortization: 14069000
Net tangible assets: 4203000
Owner earnings: -152996000
Return on net tangible assets (%): -3640.1617891981923
Buffett classification: The Gruesome
Stock price: 32.58
Shares outstanding: 13086244
Book value: 37183000
P/B ratio: 11.466256878681117
Market cap (USD): 426349829.52
Debt to equity: 16.547696527983216
Current ratio: 1.1652154849407677
Quick ratio: 1.1652154849407677
COGS to revenue (%): 111.92585611058749
SG&A to revenue (%): 40.445153338650044
Free cash flow (dilution-adjusted): -198236000
Buyback yield (%): 0
Retained earnings: -2076238000
Receivables turnover: 0.17083737936227977
Capitalized R&D asset: 27658950
ROCI (R&D-adjusted, %): -63.65449948893058
FCF margin (%): -95.81478527755624
Revenue growth (%): 72.33638476339617
Rule of 40 score: -23.47840051416007
Financial ratios for BIO.AX — annual report dated 2022-06-30
Total revenue: 2836490.3448275863
Gross profit: 1639764.8275862068
Operating income: -3291995.8620689656
Net income: -3131434.4827586208
Capital expenditures: 68511.03448275862
Depreciation & amortization: 57647.58620689655
Net tangible assets: 4500032.413793104
Owner earnings: -3142297.9310344825
Return on net tangible assets (%): -69.82833993379664
Buffett classification: The Gruesome
Stock price: 0.055172413793103454
Shares outstanding: 227998033
Book value: 5318995.862068966
P/B ratio: 2.364958000887904
Market cap (USD): 12579201.820689656
Debt to equity: 0.06055693166872046
Current ratio: 7.2229991484953615
Quick ratio: 5.199149642720455
Interest coverage ratio: -141.09526765392687
COGS to revenue (%): 42.19036103625874
SG&A to revenue (%): 141.9039215776855
Free cash flow (dilution-adjusted): -2447675.1724137934
Buyback yield (%): 6.2355307688115005
Retained earnings: -10020848.27586207
Inventory turnover: 0.7026771147205877
Receivables turnover: 5.175862316314576
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -59.019012617873734
FCF margin (%): -86.29238512576616
Rule of 40 score: -86.29238512576616
Financial ratios for BIO.AX — annual report dated 2023-06-30
Total revenue: 4791795.36423841
Gross profit: 2831475.4966887417
Operating income: -2221440.3973509935
Net income: -2038759.6026490065
Capital expenditures: 265522.5165562914
Depreciation & amortization: 145945.03311258278
Net tangible assets: 2375009.9337748345
Owner earnings: -2158337.086092715
Return on net tangible assets (%): -90.87697088753897
Buffett classification: The Gruesome
Stock price: 0.046357615894039736
Shares outstanding: 227998033
Book value: 4375880.132450331
P/B ratio: 2.4153872863268075
Market cap (USD): 10569445.238410596
Debt to equity: 0.17337772276351143
Current ratio: 3.278992735701279
Quick ratio: 1.2556012518140656
Interest coverage ratio: -35.80941146328184
COGS to revenue (%): 40.90992453850822
SG&A to revenue (%): 96.99399262895699
Free cash flow (dilution-adjusted): -2581353.642384106
Buyback yield (%): 0
Retained earnings: -11654998.013245033
Inventory turnover: 0.48986682615577193
Receivables turnover: 5.01413054626193
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -44.17016384851091
FCF margin (%): -53.870281307273146
Revenue growth (%): 68.93395646406388
Rule of 40 score: 15.063675156790737
Financial ratios for BIO.AX — annual report dated 2024-06-30
Total revenue: 8672598
Gross profit: 5274147.333333333
Operating income: -1289602
Net income: -1113468
Capital expenditures: 14404.666666666666
Depreciation & amortization: 161040
Net tangible assets: 1935685.3333333333
Owner earnings: -966832.6666666666
Return on net tangible assets (%): -49.94782209780653
Buffett classification: The Gruesome
Stock price: 0.38666666666666666
Shares outstanding: 227998033
Book value: 1935685.3333333335
P/B ratio: 45.5441997252997
Market cap (USD): 88159239.42666666
Debt to equity: 0.4464778710589324
Current ratio: 1.4986782405755743
Quick ratio: 1.1315024740824529
Interest coverage ratio: -12.928340852130326
COGS to revenue (%): 39.186073961535705
SG&A to revenue (%): 70.68336385475263
Free cash flow (dilution-adjusted): -123608.66666666667
Buyback yield (%): 0
Retained earnings: -12845232.666666666
Inventory turnover: 2.6992153351438675
Receivables turnover: 4.532681979441272
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -61.737553251110334
FCF margin (%): -1.4252784075390867
Revenue growth (%): 80.98848846351747
Rule of 40 score: 79.56321005597839
Financial ratios for BVFL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.13
Shares outstanding: 8658965
Market cap (USD): 113692210.45
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BVFL — annual report dated 2022-12-31
Total revenue: 35339000
Net income: 10524000
Capital expenditures: 437000
Operating cash flow: 9714000
Depreciation & amortization: 1043000
Net tangible assets: 82136000
Owner earnings: 11130000
Return on net tangible assets (%): 13.550696405960846
Buffett classification: The Gruesome
Stock price: 16.33
P/E ratio: 13.436041281832
Shares outstanding: 8658965
Book value: 97751000
P/B ratio: 1.4465417075017135
Market cap (USD): 141400898.45
Debt to equity: 0.5016726171599267
Effective tax rate (%): 27.685013399299113
COGS to revenue (%): 0
SG&A to revenue (%): 29.35000990407199
Free cash flow (dilution-adjusted): 8954000
Buyback yield (%): 0
Retained earnings: 84612000
Receivables turnover: 11.97120596205962
Capitalized R&D asset: 0
FCF margin (%): 25.337445881320917
Rule of 40 score: 25.337445881320917
Financial ratios for BVFL — annual report dated 2023-12-31
Total revenue: 37798000
Net income: 13707000
Capital expenditures: 489000
Operating cash flow: 15194000
Depreciation & amortization: 1052000
Net tangible assets: 183633000
Owner earnings: 14270000
Return on net tangible assets (%): 7.770934418105678
Buffett classification: The Gruesome
Stock price: 14.18
P/E ratio: 8.957767833953454
Shares outstanding: 8658965
Book value: 199065000
P/B ratio: 0.6168041780323009
Market cap (USD): 122784123.7
Debt to equity: 0.18712983196443372
Effective tax rate (%): 26.39351304908173
COGS to revenue (%): 0
SG&A to revenue (%): 33.43034022964178
Free cash flow (dilution-adjusted): 14171000
Buyback yield (%): 0
Retained earnings: 97772000
Receivables turnover: 11.527294906983837
Capitalized R&D asset: 0
FCF margin (%): 37.49140166146357
Revenue growth (%): 6.958318005602875
Rule of 40 score: 44.44971966706645
Financial ratios for BVFL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.35
Shares outstanding: 8658965
Market cap (USD): 132915112.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BVFL — quarterly report dated 2024-12-31
Capital expenditures: 17000
Buffett classification: The Gruesome
Stock price: 17.22
Shares outstanding: 8658965
Market cap (USD): 149107377.29999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BVFL — annual report dated 2024-12-31
Total revenue: 37703000
Net income: 11723000
Capital expenditures: 611000
Operating cash flow: 16063000
Depreciation & amortization: 1003000
Net tangible assets: 180248000
Owner earnings: 12115000
Return on net tangible assets (%): 6.721295104522658
Buffett classification: The Gruesome
Stock price: 17.22
P/E ratio: 12.719216693679092
Shares outstanding: 8658965
Book value: 195499000
P/B ratio: 0.7627014833835466
Market cap (USD): 149107377.29999998
Debt to equity: 0.2551573153826874
Effective tax rate (%): 28.54443496281848
COGS to revenue (%): 0
SG&A to revenue (%): 38.07124101530382
Free cash flow (dilution-adjusted): 13373000
Buyback yield (%): 11.873993306433137
Retained earnings: 109495000
Receivables turnover: 11.927554571338185
Capitalized R&D asset: 0
FCF margin (%): 35.469326048325065
Revenue growth (%): -0.25133604952642996
Rule of 40 score: 35.217989998798636
Financial ratios for BVFL — quarterly report dated 2025-03-31
Total revenue: 9173000
Net income: 2099000
Capital expenditures: 217000
Operating cash flow: 4807000
Depreciation & amortization: 243000
Net tangible assets: 182867000
Owner earnings: 2125000
Return on net tangible assets (%): 1.1620467334182767
Buffett classification: The Gruesome
Stock price: 15.26
P/E ratio: 15.737947343973321
Shares outstanding: 8658965
Book value: 198073000
P/B ratio: 0.6671066016064784
Market cap (USD): 132135805.89999999
Debt to equity: 0.25203838988655697
Effective tax rate (%): 22.201630837657525
COGS to revenue (%): 0
SG&A to revenue (%): 50.267088193611684
Free cash flow (dilution-adjusted): 3328000
Buyback yield (%): 0.7424179943643875
Retained earnings: 111594000
Receivables turnover: 2.93912207625761
Capitalized R&D asset: 0
FCF margin (%): 36.280388095497656
Rule of 40 score: 36.280388095497656
Financial ratios for BVFL — quarterly report dated 2025-06-30
Total revenue: 9870000
Net income: 2861000
Capital expenditures: 139000
Operating cash flow: 2341000
Depreciation & amortization: 245000
Net tangible assets: 182830000
Owner earnings: 2967000
Return on net tangible assets (%): 1.622819012197123
Buffett classification: The Gruesome
Stock price: 15.23
P/E ratio: 26.58791067540323
Shares outstanding: 8658965
Book value: 197991000
P/B ratio: 0.6660708666050478
Market cap (USD): 131876036.95
Debt to equity: 0.17657873337676966
Effective tax rate (%): 27.33045466090932
COGS to revenue (%): 0
SG&A to revenue (%): 41.59067882472138
Free cash flow (dilution-adjusted): 936000
Buyback yield (%): 3.248505262274641
Retained earnings: 114455000
Receivables turnover: 3.0434782608695654
Capitalized R&D asset: 0
FCF margin (%): 9.483282674772036
Revenue growth (%): 7.598386569279407
Rule of 40 score: 17.081669244051444
Financial ratios for BVFL — quarterly report dated 2025-09-30
Total revenue: 10042000
Net income: 3730000
Capital expenditures: 13000
Operating cash flow: 8437000
Depreciation & amortization: 251000
Net tangible assets: 175094000
Owner earnings: 3968000
Return on net tangible assets (%): 2.266211292220179
Buffett classification: The Gruesome
Stock price: 16.12
P/E ratio: 16.062429896432683
Shares outstanding: 8658965
Book value: 190210000
P/B ratio: 0.733833740602492
Market cap (USD): 139582515.8
Debt to equity: 0.18400714999211398
Effective tax rate (%): 27.852998065764023
COGS to revenue (%): 0
SG&A to revenue (%): 41.346345349531965
Free cash flow (dilution-adjusted): 7332000
Buyback yield (%): 9.139396812619992
Retained earnings: 118185000
Receivables turnover: 3.2935388652017057
Capitalized R&D asset: 0
FCF margin (%): 73.01334395538738
Revenue growth (%): 1.7426545086119554
Rule of 40 score: 74.75599846399933
Financial ratios for BVFL — annual report dated 2025-12-31
Total revenue: 39655000
Net income: 13495000
Capital expenditures: 237000
Operating cash flow: 19024000
Depreciation & amortization: 813000
Net tangible assets: 168733000
Owner earnings: 14071000
Return on net tangible assets (%): 8.33921046861017
Buffett classification: The Gruesome
Stock price: 18.14
P/E ratio: 11.639394227491664
Shares outstanding: 8658965
Book value: 183804000
P/B ratio: 0.8545713101999957
Market cap (USD): 157073625.1
Debt to equity: 0.19042023024526125
Effective tax rate (%): 28.457827492975667
COGS to revenue (%): 0
SG&A to revenue (%): 41.8711385701677
Free cash flow (dilution-adjusted): 14445000
Buyback yield (%): 19.113966447827273
Retained earnings: 122990000
Receivables turnover: 12.592886630676405
Capitalized R&D asset: 0
FCF margin (%): 36.426680116000504
Revenue growth (%): 5.1773068456091025
Rule of 40 score: 41.60398696160961
Financial ratios for BVFL — quarterly report dated 2025-12-31
Total revenue: 10570000
Net income: 4805000
Capital expenditures: 132000
Operating cash flow: 3439000
Depreciation & amortization: 74000
Net tangible assets: 168733000
Owner earnings: 4747000
Return on net tangible assets (%): 2.8133204530234157
Buffett classification: The Gruesome
Stock price: 18.14
P/E ratio: 11.639394227491664
Shares outstanding: 8658965
Book value: 183804000
P/B ratio: 0.8545713101999957
Market cap (USD): 157073625.1
Debt to equity: 0.19042023024526125
Effective tax rate (%): 31.911577157432337
COGS to revenue (%): 0
SG&A to revenue (%): 35.354777672658464
Free cash flow (dilution-adjusted): 2849000
Buyback yield (%): 7.640366097337879
Retained earnings: 122990000
Receivables turnover: 3.3566211495712923
Capitalized R&D asset: 0
FCF margin (%): 26.953642384105958
Revenue growth (%): 5.257916749651463
Rule of 40 score: 32.21155913375742
Financial ratios for CCEP — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 49.11
Shares outstanding: 442287374
Market cap (USD): 21720732937.14
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCEP — annual report dated 2022-12-31
Total revenue: 20867469879.518074
Gross profit: 7498795180.722892
Operating income: 2690361445.7831326
Net income: 1832530120.4819279
Capital expenditures: 589156626.5060241
Operating cash flow: 3532530120.481928
Depreciation & amortization: 983132530.120482
Net tangible assets: -11636144578.313253
Owner earnings: 2226506024.096386
Return on net tangible assets (%): -19.13439635535308
Capex to operating income (%): 21.898790864308108
Buffett classification: The Great
Stock price: 50.25
P/E ratio: 12.128008317623273
Shares outstanding: 442287374
Book value: 8972289156.626503
P/B ratio: 2.4770646771995444
Market cap (USD): 22224940543.5
Debt to equity: 1.5988988854572317
Current ratio: 0.8947080541501435
Quick ratio: 0.70600300834131
Effective tax rate (%): 22.278998467041387
Interest coverage ratio: 13.78395061728395
COGS to revenue (%): 64.06466512702079
SG&A to revenue (%): 11.47228637413395
Free cash flow (dilution-adjusted): 2766265060.240964
Buyback yield (%): 0
Retained earnings: 8949397590.361446
Inventory turnover: 8.040579710144927
Receivables turnover: 7.023519870235199
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.15
FCF margin (%): 13.256351039260968
Rule of 40 score: 13.256351039260968
Financial ratios for CCEP — annual report dated 2023-12-31
Total revenue: 23167088607.594936
Gross profit: 8506329113.92405
Operating income: 2948101265.822785
Net income: 2112658227.8481011
Capital expenditures: 678481012.6582278
Operating cash flow: 3551898734.177215
Depreciation & amortization: 1002531645.5696203
Net tangible assets: -11307594936.70886
Owner earnings: 2436708860.7594934
Return on net tangible assets (%): -21.549311541475426
Capex to operating income (%): 23.014169171318162
Buffett classification: The Great
Stock price: 62.56
P/E ratio: 13.097006298848175
Shares outstanding: 442287374
Book value: 10096202531.645569
P/B ratio: 2.7405846931767304
Market cap (USD): 27669498117.440002
Debt to equity: 1.4287863590772316
Current ratio: 0.9075295410827151
Quick ratio: 0.7212146194009343
Effective tax rate (%): 24.23967317294598
Interest coverage ratio: 14.376543209876544
COGS to revenue (%): 63.28270134411539
SG&A to revenue (%): 12.03147197027647
Free cash flow (dilution-adjusted): 2451898734.177215
Buyback yield (%): 0
Retained earnings: 10418987341.772152
Inventory turnover: 8.541297935103245
Receivables turnover: 7.185708676874755
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.597925009100837
FCF margin (%): 10.583542782209594
Revenue growth (%): 11.020112842400668
Rule of 40 score: 21.603655624610262
Financial ratios for CCEP — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -11183750000
Buffett classification: The Gruesome
Stock price: 74.05
Shares outstanding: 442287374
Book value: 11231250000
P/B ratio: 2.9160939383149693
Market cap (USD): 32751380044.699997
Debt to equity: 1.2611018363939899
Current ratio: 0.8145784758866118
Quick ratio: 0.6172536507546939
Buyback yield (%): 0
Retained earnings: 11002500000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCEP — annual report dated 2024-12-31
Total revenue: 25547500000
Gross profit: 9013750000
Operating income: 3168750000
Net income: 1805000000
Capital expenditures: 970000000
Operating cash flow: 3826250000
Depreciation & amortization: 1166250000
Net tangible assets: -11183750000
Owner earnings: 2001250000
Return on net tangible assets (%): -17.894266234492008
Capex to operating income (%): 30.61143984220907
Buffett classification: The Good
Stock price: 74.05
P/E ratio: 18.144808889030468
Shares outstanding: 442287374
Book value: 11231250000
P/B ratio: 2.9160939383149693
Market cap (USD): 32751380044.699997
Debt to equity: 1.2611018363939899
Current ratio: 0.8145784758866118
Quick ratio: 0.6172536507546939
Effective tax rate (%): 25.413223140495866
Interest coverage ratio: 10.475206611570249
COGS to revenue (%): 64.71768274782268
SG&A to revenue (%): 11.517761033369215
Free cash flow (dilution-adjusted): 2596250000
Buyback yield (%): 0
Retained earnings: 11002500000
Inventory turnover: 8.225746268656716
Receivables turnover: 7.971138845553822
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.04527035859004
FCF margin (%): 10.162442509051766
Revenue growth (%): 10.274969948639495
Rule of 40 score: 20.43741245769126
Financial ratios for CCEP — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -12260273972.60274
Buffett classification: The Gruesome
Stock price: 90.31
Shares outstanding: 442287374
Book value: 11650684931.506851
P/B ratio: 3.4283797888931447
Market cap (USD): 39942972745.94
Debt to equity: 1.4123456790123454
Current ratio: 0.833815028901734
Quick ratio: 0.6471924029727497
Buyback yield (%): 0
Retained earnings: 12260273972.60274
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHRN — annual report dated 2025-05-31
Total revenue: 84376000
Gross profit: -30924000
Operating income: -57624000
Net income: -72730000
Capital expenditures: 1376000
Operating cash flow: -7222000
Depreciation & amortization: 80656000
Net tangible assets: 76152000
Owner earnings: 6550000
Buffett classification: The Gruesome
Stock price: 4.53
Shares outstanding: 145214825
Book value: 76152000
P/B ratio: 8.638291276000631
Market cap (USD): 657823157.25
Debt to equity: 2.887908393738838
Current ratio: 0.04065901997107113
Quick ratio: 0.04065901997107113
Interest coverage ratio: -3.3119144778435543
COGS to revenue (%): 136.65023229354318
SG&A to revenue (%): 19.199772447141367
Free cash flow (dilution-adjusted): -7135000
Buyback yield (%): 0
Receivables turnover: 22.27455121436114
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -39.31446661026662
FCF margin (%): -8.456196074713189
Rule of 40 score: -8.456196074713189
Financial ratios for CHRW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 97.37
Shares outstanding: 117873042
Market cap (USD): 11477298099.54
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHRW — annual report dated 2022-12-31
Total revenue: 24696625000
Gross profit: 1870197000
Operating income: 1266782000
Net income: 940524000
Capital expenditures: 1664000
Operating cash flow: 1650171000
Depreciation & amortization: 92776000
Net tangible assets: -270217000
Owner earnings: 1031636000
Return on net tangible assets (%): -381.7805689501401
Capex to operating income (%): 0.13135646070120982
Buffett classification: The Great
Stock price: 84.62
P/E ratio: 10.605169898949947
Shares outstanding: 117873042
Book value: 1353422000
P/B ratio: 7.3697758822008215
Market cap (USD): 9974416814.04
Debt to equity: 1.7445911179218307
Current ratio: 1.0801678798814993
Quick ratio: 1.0801678798814993
Effective tax rate (%): 19.390451376241145
Interest coverage ratio: 12.665666836637772
COGS to revenue (%): 92.42731749783624
SG&A to revenue (%): 2.4433095615291562
Free cash flow (dilution-adjusted): 1430997000
Buyback yield (%): 14.636444688626238
Retained earnings: 5590440000
Receivables turnover: 7.600481634788496
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 48.13528228012792
FCF margin (%): 5.794301852985985
Rule of 40 score: 5.794301852985985
Financial ratios for CHRW — annual report dated 2023-12-31
Total revenue: 17596443000
Gross profit: 1138873000
Operating income: 514607000
Net income: 325129000
Capital expenditures: 28665000
Operating cash flow: 731946000
Depreciation & amortization: 98985000
Net tangible assets: -201094000
Owner earnings: 395449000
Return on net tangible assets (%): -196.64883089500432
Capex to operating income (%): 5.570270128466967
Buffett classification: The Great
Stock price: 81.99
P/E ratio: 29.7248498706052
Shares outstanding: 117873042
Book value: 1418697000
P/B ratio: 6.812173926906167
Market cap (USD): 9664410713.58
Debt to equity: 1.3762635714320959
Current ratio: 1.4038517675255227
Quick ratio: 1.4038517675255227
Effective tax rate (%): 20.54249167860093
Interest coverage ratio: 4.881446770567534
COGS to revenue (%): 93.52782264006424
SG&A to revenue (%): 3.5476829038686963
Free cash flow (dilution-adjusted): 589666000
Buyback yield (%): 0.6610232314551062
Retained earnings: 5620790000
Receivables turnover: 6.841905264782766
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.21684392240601
FCF margin (%): 3.3510522552768194
Revenue growth (%): -28.74960445000076
Rule of 40 score: -25.39855219472394
Financial ratios for CHRW — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 107
Shares outstanding: 117873042
Market cap (USD): 12612415494
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHRW — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 100.76
Shares outstanding: 117873042
Market cap (USD): 11876887711.92
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHRW — annual report dated 2024-12-31
Total revenue: 17724956000
Gross profit: 1308765000
Operating income: 669141000
Net income: 465690000
Capital expenditures: 22653000
Operating cash flow: 509084000
Depreciation & amortization: 97160000
Net tangible assets: 162787000
Owner earnings: 540197000
Return on net tangible assets (%): 331.84283757302484
Capex to operating income (%): 3.385385143041601
Buffett classification: The Great
Stock price: 100.76
P/E ratio: 25.503849582168396
Shares outstanding: 117873042
Book value: 1722051000
P/B ratio: 6.896943070745292
Market cap (USD): 11876887711.92
Debt to equity: 1.0110803919279976
Current ratio: 1.2773046387411404
Quick ratio: 1.2773046387411404
Effective tax rate (%): 19.59827625499824
Interest coverage ratio: 7.440108075652957
COGS to revenue (%): 92.61625811652226
SG&A to revenue (%): 3.6086069832839076
Free cash flow (dilution-adjusted): 350206000
Buyback yield (%): 0
Retained earnings: 5786337000
Receivables turnover: 6.8593942588372245
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.50705341490225
FCF margin (%): 1.9757792346564922
Revenue growth (%): 0.7303351023840443
Rule of 40 score: 2.7061143370405363
Financial ratios for CHRW — quarterly report dated 2025-03-31
Total revenue: 4046740000
Gross profit: 324535000
Operating income: 176853000
Net income: 135302000
Capital expenditures: 3348000
Operating cash flow: 106531000
Depreciation & amortization: 25642000
Net tangible assets: 276854000
Owner earnings: 157596000
Return on net tangible assets (%): 56.92386600879886
Capex to operating income (%): 1.8930976573764653
Buffett classification: The Great
Stock price: 100.49
P/E ratio: 21.88633943064404
Shares outstanding: 117873042
Book value: 1734725000
P/B ratio: 6.8282073473201805
Market cap (USD): 11845061990.58
Debt to equity: 0.9965787084408192
Current ratio: 1.291760277286253
Quick ratio: 1.291760277286253
Effective tax rate (%): 13.711559801533143
Interest coverage ratio: 8.820158595581267
COGS to revenue (%): 91.9803347880022
SG&A to revenue (%): 3.6494066829101945
Free cash flow (dilution-adjusted): 67303000
Buyback yield (%): 0.4026994543205793
Retained earnings: 5847221000
Receivables turnover: 1.509791704752773
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.9692198022849725
FCF margin (%): 1.6631411951348491
Rule of 40 score: 1.6631411951348491
Financial ratios for CHRW — quarterly report dated 2025-06-30
Total revenue: 4136543000
Gross profit: 357909000
Operating income: 215919000
Net income: 152471000
Capital expenditures: 7292000
Operating cash flow: 227128000
Depreciation & amortization: 24866000
Net tangible assets: 319867000
Owner earnings: 170045000
Return on net tangible assets (%): 53.16115760613005
Capex to operating income (%): 3.3771923730658258
Buffett classification: The Great
Stock price: 94.78
P/E ratio: 38.82229021054789
Shares outstanding: 117873042
Book value: 1784387000
P/B ratio: 6.260977535007821
Market cap (USD): 11172006920.76
Debt to equity: 0.9480706819764995
Current ratio: 1.3126852536262343
Quick ratio: 1.3126852536262343
Effective tax rate (%): 21.36332925892116
COGS to revenue (%): 91.34763013463174
SG&A to revenue (%): 3.432576429158358
Free cash flow (dilution-adjusted): 186087000
Buyback yield (%): 0.7256261169097561
Retained earnings: 5923990000
Receivables turnover: 1.5168958030113175
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.135289576718598
FCF margin (%): 4.4986115217465406
Revenue growth (%): 2.2191442988677306
Rule of 40 score: 6.717755820614271
Financial ratios for CHRW — quarterly report dated 2025-09-30
Total revenue: 4136846000
Gross profit: 356775000
Operating income: 220836000
Net income: 162987000
Capital expenditures: 5975000
Operating cash flow: 275446000
Depreciation & amortization: 25829000
Net tangible assets: 395149000
Owner earnings: 182841000
Return on net tangible assets (%): 46.27140648211181
Capex to operating income (%): 2.7056277056277054
Buffett classification: The Great
Stock price: 131.42
P/E ratio: 34.36612649667229
Shares outstanding: 117873042
Book value: 1857041000
P/B ratio: 8.34169799139599
Market cap (USD): 15490875179.64
Debt to equity: 0.8090386803522378
Current ratio: 1.5851285622387303
Quick ratio: 1.5851285622387303
Effective tax rate (%): 20.584795891518947
Interest coverage ratio: 14.154339187283682
COGS to revenue (%): 91.37567605852381
SG&A to revenue (%): 3.2860541581678406
Free cash flow (dilution-adjusted): 238080000
Buyback yield (%): 0.7197140168460836
Retained earnings: 6011521000
Receivables turnover: 1.520716443280532
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.604370016502252
FCF margin (%): 5.755109085520709
Revenue growth (%): 0.007324957095816482
Rule of 40 score: 5.762434042616525
Financial ratios for CHRW — annual report dated 2025-12-31
Total revenue: 16232763000
Gross profit: 1359252000
Operating income: 794961000
Net income: 587081000
Capital expenditures: 19628000
Operating cash flow: 914519000
Depreciation & amortization: 102818000
Net tangible assets: 279202000
Owner earnings: 670271000
Return on net tangible assets (%): 240.0666900666901
Capex to operating income (%): 2.4690519409128244
Buffett classification: The Great
Stock price: 160.21
P/E ratio: 32.16666875409015
Shares outstanding: 117873042
Book value: 1845647000
P/B ratio: 10.231880776128913
Market cap (USD): 18884440058.82
Debt to equity: 0.7560416482675181
Current ratio: 1.527837497584214
Quick ratio: 1.527837497584214
Effective tax rate (%): 18.738277849062296
Interest coverage ratio: 10.964374379344587
COGS to revenue (%): 91.6264902037934
SG&A to revenue (%): 3.4762473893076615
Free cash flow (dilution-adjusted): 763906000
Buyback yield (%): 1.8780117329153183
Retained earnings: 6071118000
Receivables turnover: 6.448558557484894
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.63712690354386
FCF margin (%): 4.705951784055493
Revenue growth (%): -8.418599177340694
Rule of 40 score: -3.7126473932852004
Financial ratios for CHRW — quarterly report dated 2025-12-31
Total revenue: 3912634000
Gross profit: 320033000
Operating income: 181353000
Net income: 136321000
Capital expenditures: 3013000
Operating cash flow: 305414000
Depreciation & amortization: 26481000
Net tangible assets: 279202000
Owner earnings: 159789000
Return on net tangible assets (%): 57.230607230607234
Capex to operating income (%): 1.661400693674767
Buffett classification: The Great
Stock price: 160.21
P/E ratio: 32.16666875409015
Shares outstanding: 117873042
Book value: 1845647000
P/B ratio: 10.231880776128913
Market cap (USD): 18884440058.82
Debt to equity: 0.7560416482675181
Current ratio: 1.527837497584214
Quick ratio: 1.527837497584214
Effective tax rate (%): 18.13929189085319
Interest coverage ratio: 12.2329173693086
COGS to revenue (%): 91.82052295205736
SG&A to revenue (%): 3.5444153478193976
Free cash flow (dilution-adjusted): 272436000
Buyback yield (%): 0.6057632614135767
Retained earnings: 6071118000
Receivables turnover: 1.5543163824301724
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.62042273185526
FCF margin (%): 6.962981970713335
Revenue growth (%): -5.419877848969964
Rule of 40 score: 1.5431041217433705
Financial ratios for CPT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 151.74
Shares outstanding: 99090596
Market cap (USD): 15036007037.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPT — annual report dated 2022-12-31
Total revenue: 1422756000
Gross profit: 893558000
Operating income: 261313000
Net income: 661508000
Capital expenditures: 449431000
Operating cash flow: 744712000
Depreciation & amortization: 577020000
Net tangible assets: 4986620000
Owner earnings: 789097000
Return on net tangible assets (%): 15.82428578877075
Capex to operating income (%): 171.98952979759906
Buffett classification: The Gruesome
Stock price: 97.75
P/E ratio: 14.64246200952974
Shares outstanding: 99090596
Book value: 5056921000
P/B ratio: 1.9154156766538373
Market cap (USD): 9686105759
Debt to equity: 0.7278935146505155
Current ratio: 0.06806334783636689
Quick ratio: 0.06806334783636689
Effective tax rate (%): 0.4463681046963463
Interest coverage ratio: 2.3038598532938357
COGS to revenue (%): 37.19527452353039
SG&A to revenue (%): 4.246195412284328
Free cash flow (dilution-adjusted): 282459000
Buyback yield (%): 0
Retained earnings: -581532000
Receivables turnover: 106.46183777312181
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.944243777115722
FCF margin (%): 19.852947378187125
Rule of 40 score: 19.852947378187125
Financial ratios for CPT — annual report dated 2023-12-31
Total revenue: 1542027000
Gross profit: 957684000
Operating income: 323816000
Net income: 410553000
Capital expenditures: 410934000
Operating cash flow: 794950000
Depreciation & amortization: 574813000
Net tangible assets: 4980757000
Owner earnings: 574432000
Return on net tangible assets (%): 11.533026003878527
Capex to operating income (%): 126.90355016429082
Buffett classification: The Gruesome
Stock price: 90.28
P/E ratio: 21.789876110709216
Shares outstanding: 99090596
Book value: 5051771000
P/B ratio: 1.7708441271150257
Market cap (USD): 8945899006.88
Debt to equity: 0.7354719760654234
Current ratio: 0.6517438300705634
Quick ratio: 0.6517438300705634
Effective tax rate (%): 0.8812104209771536
Interest coverage ratio: 2.4274972825068404
COGS to revenue (%): 37.894472664875515
SG&A to revenue (%): 4.053495820760596
Free cash flow (dilution-adjusted): 369504000
Buyback yield (%): 0
Retained earnings: -613651000
Receivables turnover: 129.52767744645107
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.616361226928968
FCF margin (%): 23.96222634234031
Revenue growth (%): 8.383095906817474
Rule of 40 score: 32.34532224915778
Financial ratios for CPT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 115.58
Shares outstanding: 99090596
Market cap (USD): 11452891085.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 109.52
Shares outstanding: 99090596
Market cap (USD): 10852402073.92
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPT — annual report dated 2024-12-31
Total revenue: 1543842000
Gross profit: 944506000
Operating income: 297264000
Net income: 170840000
Capital expenditures: 393735000
Operating cash flow: 774877000
Depreciation & amortization: 582014000
Net tangible assets: 4675198000
Owner earnings: 359119000
Return on net tangible assets (%): 7.681364511192895
Capex to operating income (%): 132.45297109639915
Buffett classification: The Gruesome
Stock price: 109.52
P/E ratio: 63.52377706579255
Shares outstanding: 99090596
Book value: 4747189000
P/B ratio: 2.2860690977165645
Market cap (USD): 10852402073.92
Debt to equity: 0.7342431489456182
Current ratio: 0.10116462086593969
Quick ratio: 0.10116462086593969
Effective tax rate (%): 1.6838737152262238
Interest coverage ratio: 2.2899048646150293
COGS to revenue (%): 38.821071068153344
SG&A to revenue (%): 4.68733199381802
Free cash flow (dilution-adjusted): 365976000
Buyback yield (%): 0.46069984930018876
Retained earnings: -897931000
Receivables turnover: 171.7097097097097
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.520047100689447
FCF margin (%): 23.705534633725474
Revenue growth (%): 0.11770221922184242
Rule of 40 score: 23.823236852947318
Financial ratios for CPT — quarterly report dated 2025-03-31
Total revenue: 390565000
Gross profit: 240579000
Operating income: 76866000
Net income: 40767000
Capital expenditures: 0
Operating cash flow: 148216000
Depreciation & amortization: 149252000
Net tangible assets: 4614956000
Owner earnings: 190019000
Return on net tangible assets (%): 4.117460708184433
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 116.43
P/E ratio: 70.75035011332696
Shares outstanding: 99090596
Book value: 4687218000
P/B ratio: 2.4613999375066404
Market cap (USD): 11537118092.28
Debt to equity: 0.7969910936508607
Current ratio: 0.1307852881591171
Quick ratio: 0.1307852881591171
Effective tax rate (%): 1.3526593427866234
Interest coverage ratio: 2.274815034033738
COGS to revenue (%): 38.40231459552187
SG&A to revenue (%): 4.339354524855018
Free cash flow (dilution-adjusted): 65761000
Buyback yield (%): 0
Retained earnings: -973416000
Receivables turnover: 43.63854748603352
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8900895809980824
FCF margin (%): 16.83740222498176
Rule of 40 score: 16.83740222498176
Financial ratios for CPT — quarterly report dated 2025-06-30
Total revenue: 396509000
Gross profit: 242497000
Operating income: 71839000
Net income: 82594000
Capital expenditures: 116820000
Operating cash flow: 230663000
Depreciation & amortization: 152108000
Net tangible assets: 4587485000
Owner earnings: 117882000
Return on net tangible assets (%): 2.569643279487562
Capex to operating income (%): 162.61362212725678
Buffett classification: The Gruesome
Stock price: 108.28
P/E ratio: 86.97667605547944
Shares outstanding: 99090596
Book value: 4659996000
P/B ratio: 2.3024761684087283
Market cap (USD): 10729529734.88
Debt to equity: 0.8210255974468648
Current ratio: 0.0574819353707431
Quick ratio: 0.0574819353707431
Effective tax rate (%): 1.4685356397256188
Interest coverage ratio: 2.0307844522968197
COGS to revenue (%): 38.84199349825603
SG&A to revenue (%): 5.3423755828997574
Free cash flow (dilution-adjusted): 109656000
Buyback yield (%): 0
Retained earnings: -1007075000
Receivables turnover: 44.60670491618855
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8771557097599827
FCF margin (%): 27.65536217336807
Revenue growth (%): 1.521897763496473
Rule of 40 score: 29.17725993686454
Financial ratios for CPT — quarterly report dated 2025-09-30
Total revenue: 395676000
Gross profit: 240152000
Operating income: 63631000
Net income: 113579000
Capital expenditures: 115171000
Operating cash flow: 250927000
Depreciation & amortization: 159474000
Net tangible assets: 4536293000
Owner earnings: 157882000
Return on net tangible assets (%): 3.4804189235571865
Capex to operating income (%): 180.99825556725494
Buffett classification: The Gruesome
Stock price: 103.62
P/E ratio: 43.33488460167131
Shares outstanding: 99090596
Book value: 4611775000
P/B ratio: 2.2264242200714475
Market cap (USD): 10267767557.52
Debt to equity: 0.8110187509147779
Current ratio: 0.05089146539616094
Quick ratio: 0.05089146539616094
Effective tax rate (%): 0.682062627340218
Interest coverage ratio: 1.8182883269038435
COGS to revenue (%): 39.30589674380048
SG&A to revenue (%): 4.956580636682538
Free cash flow (dilution-adjusted): 131285000
Buyback yield (%): 0.48695103117504135
Retained earnings: -1011983000
Receivables turnover: 44.512993587580155
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7809984815998152
FCF margin (%): 33.17992498913252
Revenue growth (%): -0.21008350377923327
Rule of 40 score: 32.96984148535329
Financial ratios for CPT — quarterly report dated 2025-12-31
Total revenue: 390794000
Gross profit: 243080000
Operating income: 78330000
Net income: 157958000
Capital expenditures: 130014000
Operating cash flow: 196815000
Depreciation & amortization: 150191000
Net tangible assets: 4362523000
Owner earnings: 178135000
Return on net tangible assets (%): 4.083302254223073
Capex to operating income (%): 165.98238222903103
Buffett classification: The Gruesome
Stock price: 107.9
P/E ratio: 27.0750302822501
Shares outstanding: 99090596
Book value: 4438253000
P/B ratio: 2.409027900933092
Market cap (USD): 10691875308.4
Debt to equity: 0.8789021265799855
Current ratio: 0.10127788512207975
Quick ratio: 0.10127788512207975
Effective tax rate (%): 0.908993958860025
Interest coverage ratio: 2.298482936705889
COGS to revenue (%): 37.798430886861105
SG&A to revenue (%): 5.077099443696679
Free cash flow (dilution-adjusted): 62558000
Buyback yield (%): 2.0637633121913037
Retained earnings: -969240000
Receivables turnover: 43.9885186852769
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9121345333808284
FCF margin (%): 16.007922332482075
Revenue growth (%): -1.2338377864717598
Rule of 40 score: 14.774084546010315
Financial ratios for CPT — annual report dated 2025-12-31
Total revenue: 1573544000
Gross profit: 966308000
Operating income: 288906000
Net income: 394898000
Capital expenditures: 440402000
Operating cash flow: 826621000
Depreciation & amortization: 611025000
Net tangible assets: 4362523000
Owner earnings: 565521000
Return on net tangible assets (%): 12.963163747216921
Capex to operating income (%): 152.4378171446768
Buffett classification: The Gruesome
Stock price: 107.9
P/E ratio: 27.0750302822501
Shares outstanding: 99090596
Book value: 4438253000
P/B ratio: 2.409027900933092
Market cap (USD): 10691875308.4
Debt to equity: 0.8789021265799855
Current ratio: 0.10127788512207975
Quick ratio: 0.10127788512207975
Effective tax rate (%): 1.0074777459972877
Interest coverage ratio: 2.089902270705083
COGS to revenue (%): 38.59034129328446
SG&A to revenue (%): 5.04237568190022
Free cash flow (dilution-adjusted): 369260000
Buyback yield (%): 2.531398769562553
Retained earnings: -969240000
Receivables turnover: 177.12111661413778
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.364242812471871
FCF margin (%): 23.466773093094314
Revenue growth (%): 1.9239015391471406
Rule of 40 score: 25.390674632241456
Financial ratios for CRGO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.78
Shares outstanding: 51683498
Market cap (USD): 505464610.43999994
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRGO — annual report dated 2022-12-31
Total revenue: 20303191.489361703
Gross profit: 11942553.191489363
Operating income: -23744680.851063833
Net income: -26277659.574468087
Capital expenditures: 261702.12765957447
Operating cash flow: -15859574.468085106
Depreciation & amortization: 2567021.276595745
Net tangible assets: -3652127.659574468
Owner earnings: -23972340.425531916
Buffett classification: The Gruesome
Stock price: 10.19
Shares outstanding: 51683498
Book value: 23042553.191489365
P/B ratio: 22.855750412871647
Market cap (USD): 526654844.61999995
Debt to equity: 0.1621883656509695
Current ratio: 0.7594262295081966
Quick ratio: 0.7594262295081966
Interest coverage ratio: -49.16299559471366
COGS to revenue (%): 41.178936337437776
R&D to revenue (%): 53.5341891537857
SG&A to revenue (%): 116.44223211946554
Free cash flow (dilution-adjusted): -18154255.319148935
Buyback yield (%): 0
Retained earnings: -126282978.72340426
Receivables turnover: 7.627897681854517
Capitalized R&D asset: 10869148.936170213
ROCI (R&D-adjusted, %): -44.382756679926366
FCF margin (%): -89.41577154833638
Rule of 40 score: -89.41577154833638
Financial ratios for CRGO — annual report dated 2023-12-31
Total revenue: 22534444.444444444
Gross profit: 13113333.333333332
Operating income: -31198888.888888888
Net income: -72747777.77777778
Capital expenditures: 80000
Operating cash flow: -30106666.666666664
Depreciation & amortization: 3101111.111111111
Net tangible assets: 54230000
Owner earnings: -69726666.66666667
Return on net tangible assets (%): -128.5758190423505
Buffett classification: The Gruesome
Stock price: 3.33
Shares outstanding: 51683498
Book value: 80046666.66666666
P/B ratio: 2.1500713959357047
Market cap (USD): 172106048.34
Debt to equity: 0.018031148496710253
Current ratio: 4.368717536030434
Quick ratio: 4.368717536030434
Interest coverage ratio: -72.55555555555556
COGS to revenue (%): 41.80760317538583
R&D to revenue (%): 56.73783344016567
SG&A to revenue (%): 133.80503919925053
Free cash flow (dilution-adjusted): -36224444.44444445
Buyback yield (%): 0
Retained earnings: -204643333.3333333
Receivables turnover: 5.099572542117174
Capitalized R&D asset: 20067885.342789598
ROCI (R&D-adjusted, %): -25.704993063302222
Rosenberg metric: 0.10771589833936879
FCF margin (%): -160.7514422365761
Revenue growth (%): 10.989666113585413
Rule of 40 score: -149.7617761229907
Financial ratios for CRGO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.44
Shares outstanding: 51683498
Market cap (USD): 74424237.11999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRGO — annual report dated 2024-12-31
Total revenue: 24776041.666666668
Gross profit: 16145833.333333334
Operating income: -20778125
Net income: -23428125
Capital expenditures: 47916.66666666667
Operating cash flow: -12604166.666666668
Depreciation & amortization: 3211458.3333333335
Net tangible assets: 32287500
Owner earnings: -20264583.333333336
Return on net tangible assets (%): -62.76293715318106
Buffett classification: The Gruesome
Stock price: 3.05
Shares outstanding: 51683498
Book value: 57175000
P/B ratio: 2.757055861827722
Market cap (USD): 157634668.89999998
Debt to equity: 0.017380848272846524
Current ratio: 2.662912262461734
Quick ratio: 2.662912262461734
Interest coverage ratio: -112.06179775280897
COGS to revenue (%): 34.83287786420013
R&D to revenue (%): 43.19949548034475
SG&A to revenue (%): 99.90750472987176
Free cash flow (dilution-adjusted): -16430208.333333336
Buyback yield (%): 0
Retained earnings: -215281250
Receivables turnover: 6.4492950108459866
Capitalized R&D asset: 22856266.371158395
ROCI (R&D-adjusted, %): -26.357643728832148
Rosenberg metric: 0.23718171547753555
FCF margin (%): -66.31490435148203
Revenue growth (%): 9.947426162418035
Rule of 40 score: -56.367478189063995
Financial ratios for CRGO — quarterly report dated 2024-12-31
Total revenue: 6861458.333333334
Gross profit: 4638541.666666667
Operating income: -5246875
Net income: -10246875
Capital expenditures: 16666.666666666668
Operating cash flow: -4717708.333333334
Depreciation & amortization: 906250
Net tangible assets: 32287500
Owner earnings: -9357291.666666666
Return on net tangible assets (%): -28.98115885920764
Buffett classification: The Gruesome
Stock price: 3.05
Shares outstanding: 51683498
Book value: 57175000
P/B ratio: 2.757055861827722
Market cap (USD): 157634668.89999998
Debt to equity: 0.017380848272846524
Current ratio: 2.662912262461734
Quick ratio: 2.662912262461734
Interest coverage ratio: -218.99999999999997
COGS to revenue (%): 32.39714589342645
R&D to revenue (%): 42.766054349476235
SG&A to revenue (%): 176.02854106573554
Free cash flow (dilution-adjusted): -5827083.333333334
Buyback yield (%): 0
Retained earnings: -215281250
Receivables turnover: 1.786062906724512
Capitalized R&D asset: 2934375
ROCI (R&D-adjusted, %): -5.32867769849704
FCF margin (%): -84.92485198117504
Rule of 40 score: -84.92485198117504
Financial ratios for CRGO — quarterly report dated 2025-03-31
Total revenue: 7548913.043478261
Gross profit: 5042391.304347826
Operating income: -5088043.478260869
Net income: -4890217.391304348
Capital expenditures: 9782.608695652174
Operating cash flow: 315217.39130434784
Depreciation & amortization: 1019565.2173913043
Net tangible assets: 30475000
Owner earnings: -3880434.782608696
Return on net tangible assets (%): -12.73317402004494
Buffett classification: The Gruesome
Stock price: 2.39
Shares outstanding: 51683498
Book value: 56021739.13043478
P/B ratio: 2.2049219131237874
Market cap (USD): 123523560.22000001
Debt to equity: 0.03700038804811797
Current ratio: 2.353045013239188
Quick ratio: 2.353045013239188
Interest coverage ratio: -40.70434782608695
COGS to revenue (%): 33.203743700503956
R&D to revenue (%): 41.511879049676025
SG&A to revenue (%): 92.68538516918646
Free cash flow (dilution-adjusted): -459782.6086956521
Buyback yield (%): 0
Retained earnings: -229531521.73913044
Receivables turnover: 1.2538364325690559
Capitalized R&D asset: 5099726.902173913
ROCI (R&D-adjusted, %): -6.230762486233242
Rosenberg metric: 0.13762713957185405
FCF margin (%): -6.0907127429805605
Revenue growth (%): 10.019075781677996
Rule of 40 score: 3.9283630386974355
Financial ratios for CRGO — quarterly report dated 2025-06-30
Total revenue: 8750588.235294119
Gross profit: 5874117.647058824
Operating income: -5310588.235294118
Net income: -5032941.176470588
Capital expenditures: 68235.29411764706
Operating cash flow: -3320000
Depreciation & amortization: 948235.2941176471
Net tangible assets: 29887058.82352941
Owner earnings: -4152941.176470588
Return on net tangible assets (%): -13.895449535506218
Buffett classification: The Gruesome
Stock price: 2.43
Shares outstanding: 51683498
Book value: 57370588.235294126
P/B ratio: 2.1891164794217164
Market cap (USD): 125590900.14000002
Debt to equity: 0.04074643699374551
Current ratio: 2.1517725621133263
Quick ratio: 2.1517725621133263
Interest coverage ratio: -237.57894736842107
COGS to revenue (%): 32.87173971497714
R&D to revenue (%): 40.75020166711481
SG&A to revenue (%): 87.06641570314599
Free cash flow (dilution-adjusted): -4342352.94117647
Buyback yield (%): 0
Retained earnings: -253467058.82352942
Receivables turnover: 1.1665621079046427
Capitalized R&D asset: 6633802.189897698
ROCI (R&D-adjusted, %): -7.402544224350571
Rosenberg metric: 0.2654138866785009
FCF margin (%): -49.623554719010485
Revenue growth (%): 15.918519459619715
Rule of 40 score: -33.70503525939077